IS4532A - Notkun Melatóníns til meðferðar lyfjafíkla - Google Patents

Notkun Melatóníns til meðferðar lyfjafíkla

Info

Publication number
IS4532A
IS4532A IS4532A IS4532A IS4532A IS 4532 A IS4532 A IS 4532A IS 4532 A IS4532 A IS 4532A IS 4532 A IS4532 A IS 4532A IS 4532 A IS4532 A IS 4532A
Authority
IS
Iceland
Prior art keywords
melatonin
drug addicts
treat drug
treat
addicts
Prior art date
Application number
IS4532A
Other languages
English (en)
Other versions
IS1980B (is
Inventor
Zisapel Nava
Original Assignee
Neurim Pharmaceuticals (1991) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.
Publication of IS4532A publication Critical patent/IS4532A/is
Publication of IS1980B publication Critical patent/IS1980B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS4532A 1995-02-01 1997-07-25 Notkun Melatóníns til meðferðar lyfjafíkla IS1980B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
IS4532A true IS4532A (is) 1997-07-25
IS1980B IS1980B (is) 2005-01-14

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4532A IS1980B (is) 1995-02-01 1997-07-25 Notkun Melatóníns til meðferðar lyfjafíkla

Country Status (22)

Country Link
JP (1) JP4516159B2 (is)
CN (1) CN1083263C (is)
AT (1) AT408188B (is)
AU (1) AU695366B2 (is)
BG (1) BG62876B1 (is)
BR (1) BR9607169A (is)
CZ (1) CZ291349B6 (is)
DK (1) DK176081B1 (is)
EE (1) EE03384B1 (is)
FI (1) FI119586B (is)
IS (1) IS1980B (is)
LU (1) LU90118B1 (is)
LV (1) LV11940B (is)
MD (1) MD1716C2 (is)
NO (1) NO312814B1 (is)
NZ (1) NZ298878A (is)
PL (1) PL183148B1 (is)
SI (1) SI9620022A (is)
SK (1) SK284521B6 (is)
TR (1) TR199700723T1 (is)
TW (1) TW483757B (is)
WO (1) WO1996023496A1 (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60034373T2 (de) 2000-01-05 2007-12-20 Neurim Pharmaceuticals (1991) Ltd. Methode und zusammensetzung zur behandlung von resistenz gegen antihypertensiva und verwandten zuständen
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2897671T3 (es) 2012-01-26 2022-03-02 Vanda Pharmaceuticals Inc Sincronización del ritmo circadiano desincrónico del cortisol
CN105142630A (zh) 2012-12-18 2015-12-09 万达制药公司 昼夜节律紊乱的治疗
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
HUE051362T2 (hu) * 2016-10-31 2021-03-01 Neurim Pharma 1991 Melatonin minitabletták és eljárás azok elõállítására

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518468B1 (en) * 1991-05-09 1999-06-30 Neurim Pharmaceuticals (1991) Limited Melatonin containing compositions
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
PL183148B1 (pl) 2002-05-31
SI9620022A (sl) 1998-10-31
NZ298878A (en) 1999-05-28
FI973185A0 (fi) 1997-07-31
LV11940B (en) 1998-05-20
JP4516159B2 (ja) 2010-08-04
BG101803A (en) 1998-04-30
PL321630A1 (en) 1997-12-08
BG62876B1 (bg) 2000-10-31
MD1716B2 (en) 2001-08-31
ATA901396A (de) 2001-02-15
LU90118B1 (fr) 1997-11-13
CZ291349B6 (cs) 2003-02-12
MD970254A (en) 1999-05-31
NO973531D0 (no) 1997-07-31
AU695366B2 (en) 1998-08-13
EE03384B1 (et) 2001-04-16
NO312814B1 (no) 2002-07-08
SK284521B6 (sk) 2005-05-05
MX9705856A (es) 1998-07-31
MD1716C2 (ro) 2002-02-28
SK103097A3 (en) 1998-01-14
FI973185A (fi) 1997-09-30
TW483757B (en) 2002-04-21
WO1996023496A1 (en) 1996-08-08
AU4457496A (en) 1996-08-21
NO973531L (no) 1997-09-30
TR199700723T1 (xx) 1998-02-21
EE9700166A (et) 1998-02-16
IS1980B (is) 2005-01-14
DK176081B1 (da) 2006-04-18
DK89697A (da) 1997-07-30
CN1083263C (zh) 2002-04-24
JPH10513177A (ja) 1998-12-15
AT408188B (de) 2001-09-25
CN1172431A (zh) 1998-02-04
CZ240597A3 (cs) 1998-01-14
FI119586B (fi) 2009-01-15
BR9607169A (pt) 1997-11-11
LV11940A (lv) 1998-01-20

Similar Documents

Publication Publication Date Title
PT851855E (pt) Derivados acilados de melatonina e de analogos uteis como medicamentos
DE69633333D1 (de) Diphosphonatderivate von therapeutischen substanzen
FI972681A (fi) Kynsien sientenvastainen käsittely
NO20001962D0 (no) Terapeutisk anvendelse av kinolinderivater
DE69530004D1 (de) Transdermale verabreichung von apomorphin
NO973928L (no) Behandling av oljebrönn
IT1283046B1 (it) Procedimento per riconoscere mancate combustioni
LV11895A (lv) 4-benzoilpirazola atvasinajumi un to pielietojums par herbicidiem
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO20001479L (no) Behandling av atferdsforstyrrelse
ID18679A (id) Penggunaan terapi lanjutan
IT1283827B1 (it) Procedimento per riconoscere mancate combustioni
DE59500266D1 (de) Transdermales therapeutisches System zur Applikation von Naloxon
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO975718D0 (no) Behandling av insulinresistens
IS1980B (is) Notkun Melatóníns til meðferðar lyfjafíkla
DE69512760T2 (de) Verwendung von Melatonin zur Behandlung von Patienten die an Drogenabhängigkeit leiden
IS4528A (is) Bísýklískar afleiður ísóþíóþvagefnis nothæfar viðlæknismeðferð
LV11971A (lv) Pirolidinhidroksamskabes atvasinajumi un to iegusanas panemiens
NO995231D0 (no) Terapeutisk behandling av hudlidelser
FR2757059B1 (fr) Nouvelle application therapeutique des derives du pyrrole
NO964915D0 (no) Transdermal avlevering av antiepileptiske legemidler
NO981866L (no) Terapeutisk anvendelse av hemoglobin for Õ fremme sÕrheling
IT1282569B1 (it) Procedimento per riconoscere mancate combustioni
NO982562D0 (no) Sammensetning for behandling av smerte